A combination of [+] and [−]-HUPERZINE (cas 116-28-9) A improves protection against soman toxicity compared to [+]-HUPERZINE (cas 116-28-9) A in guinea pigs
-
Add time:08/28/2019 Source:sciencedirect.com
The neuropathologic mechanisms after exposure to lethal doses of nerve agent are complex and involve multiple biochemical pathways. Effective treatment requires drugs that can simultaneously protect by reversible binding to the acetylcholinesterase (AChE) and blocking cascades of seizure related brain damage, inflammation, neuronal degeneration as well as promoting induction of neuroregeneration. [−]-Huperzine A ([−]-Hup A), is a naturally occurring potent reversible AChE inhibitor that penetrates the blood–brain barrier. It also has several neuroprotective effects including modification of beta-amyloid peptide, reduction of oxidative stress, anti-inflammatory, anti-apoptotic and induction and regulation of nerve growth factor. Toxicities at higher doses restrict the neuroporotective ability of [−]-Hup A for treatment. The synthetic stereoisomer, [+]-Hup A, is less toxic due to poor AChE inhibition and is suitable for both pre-/post-exposure treatments of nerve agent toxicity. [+]-Hup A block the N-methyl-d-aspartate (NMDA)-induced seizure in rats, reduce excitatory amino acid induced neurotoxicity and also prevent soman induced toxicity with minimum performance decrement. Unique combinations of two stereo-isomers of Hup A may provide an excellent pre/post-treatment drug for the nerve agent induced seizure/status epilepticus. We investigated a combination of [+]-Hup A with a small dose of [−]-Hup A ([+] and [−]-Hup A) against soman toxicity. Our data showed that pretreatment with a combination [+] and [−]-Hup A significantly increased the survival rate and reduced behavioral abnormalities after exposure to 1.2 × LD50 soman compared to [+]-Hup A in guinea pigs. In addition, [+] and [−]-Hup A pretreatment inhibited the development of high power of EEG better than [+]-Hup A pretreatment alone. These data suggest that a combination of [+] and [−]-Hup A offers better protection than [+]-Hup A and serves as a potent medical countermeasure against lethal dose nerve agent toxicity in guinea pigs.
We also recommend Trading Suppliers and Manufacturers of HUPERZINE (cas 116-28-9). Pls Click Website Link as below: cas 116-28-9 suppliers
Prev:Variations of HUPERZINE (cas 116-28-9) A content in Lycopodiaceae species from tropics
Next:Structural analogs of HUPERZINE (cas 116-28-9) A improve survival in guinea pigs exposed to soman) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Administration of HUPERZINE (cas 116-28-9) A exerts antidepressant-like activity in a rat model of post-stroke depression08/31/2019
- Simultaneously preparative purification of HUPERZINE (cas 116-28-9) A and HUPERZINE (cas 116-28-9) B from Huperzia serrata by macroporous resin and preparative high performance liquid chromatography08/30/2019
- Structural analogs of HUPERZINE (cas 116-28-9) A improve survival in guinea pigs exposed to soman08/29/2019
- Variations of HUPERZINE (cas 116-28-9) A content in Lycopodiaceae species from tropics08/27/2019
- Microbial transformation of (−)-HUPERZINE (cas 116-28-9) A08/26/2019
- Abcb1a but not Abcg2 played a predominant role in limiting the brain distribution of HUPERZINE (cas 116-28-9) A in mice08/25/2019
- ABAD/17β-HSD10 reduction contributes to the protective mechanism of HUPERZINE (cas 116-28-9) a on the cerebral mitochondrial function in APP/PS1 mice08/24/2019
- Original ArticleHUPERZINE (cas 116-28-9)-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease08/23/2019
- HUPERZINE (cas 116-28-9) a loaded multiparticulate disintegrating tablet: Drug release mechanism of ethyl cellulose microparticles and pharmacokinetic study08/22/2019